Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qinglin Wang
Institutions:
Jiangsu Cancer Hospital,
Nanjing Medical University
Observed institutions:
Jiangsu Cancer Hospital,
Nanjing Medical University
ORCID:
0000-0003-0876-8551
Observed ORCID:
0000-0003-0876-8551
OpenAlex ID:
A5127834092
Hypoxic niche drives lineage imbalance and early tumorigenesis in EGFR -mutant lung cancer
2026
·
Fanchen Meng
, Zhijun Xia
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
5
A tumor-derived mitochondrial tsRNA drives vascular invasion of lung adenocarcinoma by promoting ribosomal assembly in endothelial cells
2026
·
Si Liang
, Qinglin Wang
, et al.
·
Cancer Letters
·
3
Decoding Brain Metastasis With Liquid Biopsy: Biomarkers and Technologies in EGFR ‐Mutant NSCLC
2026
·
Yuxiang Sun
, Qinglin Wang
, et al.
·
Cancer Medicine
·
2
Abstract 7506: CEACAM1-dominant molecular program drives immune escape in EGFR-mutant lung adenocarcinoma
2026
·
Jianyu Li
, Qinglin Wang
, et al.
·
Cancer Research
Figure S6 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S7 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S9 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S3 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S8 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S1 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Table S1 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S2 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S4 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S10 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Figure S5 from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Data from Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer
2026
·
Tongyan Liu
, Shiyi Huang
, et al.
Show more works
View as search
Works count:
16
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type